WORCESTER, Mass., Jan. 25, 2010 (GLOBE NEWSWIRE) -- Generex Biotechnology Corporation (Nasdaq:GNBT) (www.generex.com), the leader in drug delivery for metabolic diseases through the inner lining of the mouth, today announced its participation in the 2010 Arab Health Congress (http://www.arabhealthonline.com/congress/index.html) taking place January 25-28 at the Dubai International Exhibition Centre. Generex is participating in the congress through its Middle Eastern branch office, Generex MENA (Middle East and Northern Africa), which received a Commercial License from the Government of Dubai, United Arab Emirates in 2008 and opened an office in Dubai Healthcare City.
